Beijing Centergate Technologies (holding) Co., Ltd. (SHE:000931)

Market Cap	3.23B -5.9%
Revenue (ttm)	2.30B -9.6%
Net Income	15.87M -72.5%
EPS	0.02 -72.5%
Shares Out	753.13M
PE Ratio	203.39
Forward PE	n/a
Dividend	0.02 (0.48%)
Ex-Dividend Date	n/a

Volume	9,016,112
Open	4.370
Previous Close	4.180
Day's Range	4.160 - 4.370
52-Week Range	4.120 - 5.860
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHE:000931

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of exogenous opioids; Hydrocodone acetaminophen tablets for the treatment of moderate to severe pain; Ambroxol Hydrochloride injection for acute and chron...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 2,267
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000931

Financial Performance

In 2025, SHE:000931's revenue was 2.44 billion, a decrease of -3.52% compared to the previous year's 2.53 billion. Earnings were 47.89 million, a decrease of -10.65%.